09 May 2007 22:01 [Source: ICIS news]
BOSTON (ICIS news)--Sigma Aldrich Fine Chemicals (SAFC) has acquired Carlsbad, California-based Molecular Medicine Bioservices (MMB) in lieu of building its own clinical biologics manufacturing facility for its pharmaceuticals business unit, SAFC said on Wednesday at the BIO 2007 conference.
“SAFC had already designed and engineered a facility for construction in ?xml:namespace>
MMB’s core expertise revolves around the development and clinical manufacturing of viral products.
SAFC said the acquisition fits with its continued search to fill in the missing gaps in specialised niche area technologies and capabilities.
“Not many companies have this expertise in niche areas, and big pharma is looking for companies that already have these technologies ready to go,” said Wicks.
SAFC was also continuing to search for more capacity in large-scale, flexible key pharmaceutical intermediates, and in additional US-based current good manufacturing practices (cGMP) manufacturing.
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
|ICIS Global Petrochemical Index (IPEX). Download the free tabular data and a chart of the historical index|
Asian Chemical Connections